AVLN AVALYN PHARMA INC
Health Care · Russell 2000
Next earnings: Mon 16 Nov 2026 · estimated
What 7 analyst firms say about AVALYN PHARMA INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 7 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8064
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8042
Recent analyst activity · last 90 days
Our tracked history has 3 reports on AVLN from 3 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Morgan Stanley raised its target from $53.00 (set 26 May 2026) to $57.00 on 13 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Evercore ISI | Gavin Clark-Gartner | Buy | 26 May 2026 | Conflicting reports · excluded |
| Guggenheim | Seamus Fernandez | Buy | 25 May 2026 | 80.00 USD |
| Jefferies | Roger Song | Buy | 25 May 2026 | 52.00 USD |
| Morgan Stanley | Judah Frommer | Buy | 13 Aug 2026 | 57.00 USD |
| Raymond James | Tiago Fauth | Buy | 2 Oct 2026 | 60.00 USD |
| Weiss Ratings | Unnamed analyst | — | 13 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 27 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.